Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
For gut health, oral BPC-157 is generally favored over injection because the target is gastrointestinal mucosal support rather than local tendon or ligament recovery
Adults over the age of 65 Due to a number of common issues associated with ageing, including the reduced production of stomach acid, people over the age of 65 may be more prone to a B12 deficiency
Inflammatory bowel syndrome Stomach ulcers Bone fractures Injured ligaments, nerves, and muscles Tendinopathies (tendon injuries) like tennis or golf elbow, trigger fingers, or Achilles tendinitis Ulcerative colitis (short bowel syndrome, anastomosis, and fistula) Perforated cecum (part of the large intestine) Post-surgery recovery Spinal cord injuries Arrhythmia (irregular heartbeat) Periodontitis (gum damage) The outcomes for rats may differ from those for humans
B12 injections have been shown to improve brain function and sharpen cognitive performance
BPC-157 is positioned for wellness support and recovery optimization, not acute medical emergencies
Description Why 5-Amino-1MQ Is Redefining Lipid Metabolism Research Selective NNMT inhibitor -35% fat mass in 11 days without appetite reduction (preclinical model) Enzymatic Target NNMT Inhibitor Selective inhibition of nicotinamide N-methyltransferase (IC50 = 1.2 M)
US$ 25.33
US$ 27.81
US$ 21.60
